InvestorTalk Alert: Greg Fenton from Zentek Ltd. to host on Wednesday, May 15, 2024


InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Wednesday, May 15th, at 9 AM EST, featuring Greg Fenton, the CEO and Director of Zentek Ltd. (NASDAQ: ZTEK | TSXV: ZEN). To participate in this engaging discussion, please click here

Currently, Zentek holds 100,819,577 shares outstanding and has a market capitalization of CAD$153,245,758.

In preparation for tomorrow’s InvestorTalk, here are the three most recent news releases from Zentek for your review, which are listed below:

  • May 07, 2024 — Zentek Completes Case Study on HVAC Total Cost of Ownership Savings for the City of Toronto — click here
  • May 06, 2024 — Zentek and Triera Biosciences Ltd. Achieve Positive Results Against Avian Influenza (H5N1) using Multivalent Aptamer Technology — click here
  • May 03, 2024 — Zentek Announces Board and Management Changes — click here

5-Data Points from the most recent news release on May 07, 2024, titled, Zentek Completes Case Study on HVAC Total Cost of Ownership Savings for the City of Toronto:

  • Annual Cost Savings: The City of Toronto could save over $40 million annually by switching from MERV 13 filters to MERV 9A filters. Savings come from reduced labor costs, lower expenditures on air filters, reduced energy requirements, and lower waste disposal costs.
  • Energy and Emission Reductions: The switch to MERV 9A filters would result in reduced energy requirements and a decrease in carbon emissions by 3,029 tonnes of CO₂ equivalent, which is comparable to the amount absorbed by 49,976 newly planted tree seedlings growing for 10 years.
  • Waste Reduction: The use of MERV 9A filters would reduce landfill waste by approximately 947 full dumpsters.
  • Product Assessment: Zentek’s ZenGUARD™ Enhanced Air Filter product, which aims to improve HVAC filter efficiency while reducing costs and emissions, is currently being assessed for registration under the Pest Control Products Act in Canada.
  • ZenGUARD™ Technology: Zentek’s patented ZenGUARD™ technology has 99% anti-microbial activity and aims to significantly increase viral filtration efficiency in HVAC systems, as it has done for surgical masks.

(05.14.2024 at 9:00 AM EST, Source)

For more information on Zentek Ltd., click here.

For more information on the InvestorTalk pre-market series, go to

Disclaimer: The author of this Investor.News post, which is published by InvestorNews Inc., may or may not be a shareholder of any of the companies mentioned in this column. No company mentioned has sponsored or paid for this content on Investor.News, and InvestorNews Inc. does not accept opt-in payments from advertisers. While InvestorNews Inc. provides digital media services like video interviews and podcasts to advertisers, not all are paid promotions. Any sponsored video interview will be clearly marked in the summary. The author of this piece is not a licensed investment advisor and makes no recommendations to buy, sell, or hold any securities. If the author holds an investment advisor license, this will be stated in their biography. Conduct your own due diligence by reviewing public documents of any company. For our full legal notices and disclaimers, click here click here.

Leave a Reply

Your email address will not be published. Required fields are marked *